MEDICURE INC
corporate_fare Company Profile
MEDICURE INC (OTC:MCUJF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for MCUJF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-28, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for MCUJF spans 6-K, 20-F.
Recent high-impact activity:
- Medicure Completes Enrollment in Pivotal Phase 3 Trial for Ultra-Rare PNPO Deficiency
- Medicure Reports Widened Q2 Loss and Significant Cash Burn Despite Revenue Growth
- Medicure Reports Q1 Revenue Growth and Improved EBITDA, but Significant Cash Burn
- MEDICURE Reports Q1 Revenue Growth, But Significant Cash Burn Raises Liquidity Concerns
- Medicure Reports Strong Q1 Revenue Growth, Reduced Net Loss, and Improved EBITDA
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 16,610 shares in MCUJF as of the October 30, 2026 settlement, a 396.1% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 42.8% of MCUJF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
MCUJF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.